QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 限定条件 专题：中国医学科学院 北京协和医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Antitumor activity of histone deacetylase inhibitor chidamide alone or in combination with epidermal growth factor receptor tyrosine kinase inhibitor icotinib in NSCLC 期刊论文 2019, 卷号: 10, 期号: 5, 页码: 1275-1287 作者:  Zhang, Ningning;  Liang, Caixia;  Song, Wenya;  Tao, Dan;  Yao, Jiarui 收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03 Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial 期刊论文 2018, 卷号: 132 作者:  Song, Yuqin;  Zhou, Keshu;  Zou, Dehui;  Zhou, Jianfeng;  Hu, Jianda 收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03 Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial 会议论文 BLOOD, 2018-11-29 作者:  Song, Yuqin;  Zhou, Keshu;  Zou, Dehui;  Zhou, Jianfeng;  Hu, Jianda 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03 Safety, pharmacokinetic, and antitumor activity of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors. 期刊论文 2015, 卷号: 33, 期号: 15 作者:  Sun, Yongkun;  Niu, Wei;  Chi, Yihebali;  Li, Chuan;  Du, Chun-Xia 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04 Safety, pharmacokinetic, and antitumor activity of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2015-05-20 作者:  Sun, Yongkun;  Niu, Wei;  Chi, Yihebali;  Li, Chuan;  Du, Chun-Xia 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13 Synthesis and Biological Activities of New Halophenols 期刊论文 2013, 卷号: 9, 期号: 2, 页码: 303-311 作者:  Zheng, FeiLang;  Ban, ShuRong;  Feng, XiuE;  Zhao, ChengXiao;  Du, GuanHua 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13 Halophenols  furan-2-yl(phenyl)methanone  protein tyrosine kinase (PTK) inhibitor  vascular smooth muscle cell (VSMC) proliferation inhibitor  Structure-activity relationships (SAR)   Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease models 期刊论文 2013, 卷号: 75, 期号: ,SI, 页码: 201-212 作者:  Tai, Wenjiao;  Ye, Xuan;  Bao, Xiuqi;  Zhao, Baozhong;  Wang, Xiaoliang 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/13 Parkinson's disease  LPS  Neuroinflammation  Src tyrosine kinase  NADPH oxidase